Literature DB >> 27531922

Predictors of Physician Under-Recognition of Angina in Outpatients With Stable Coronary Artery Disease.

Suzanne V Arnold1, Anna Grodzinsky2, Kensey L Gosch2, Mikhail Kosiborod2, Philip G Jones2, Tracie Breeding2, Arooge Towheed2, John Beltrame2, Karen P Alexander2, John A Spertus2.   

Abstract

BACKGROUND: Under-recognition of angina by physicians may result in undertreatment with revascularization or medications that could improve patients' quality of life. We sought to describe characteristics associated with under-recognition of patients' angina. METHODS AND
RESULTS: Patients with coronary disease from 25 US cardiology outpatient practices completed the Seattle Angina Questionnaire before their clinic visit, quantifying their frequency of angina during the previous month. Immediately after the clinic visit, physicians independently quantified their patients' angina. Angina frequency was categorized as none, monthly, and daily/weekly. Among 1257 patients, 411 reported angina in the previous month, of whom 173 (42%) were under-recognized by their physician, defined as the physician reporting a lower frequency category of angina than the patient. In a hierarchical logistic model, heart failure (odds ratio, 3.06, 95% confidence interval, 1.89-4.95) and less-frequent angina (odds ratio for monthly angina [versus daily/weekly], 1.69; 95% confidence interval, 1.12-2.56) were associated with greater odds of under-recognition. No other patient or physician factors were associated with under-recognition. Significant variability across physicians (median odds ratio, 2.06) was observed.
CONCLUSIONS: Under-recognition of angina is common in routine clinical practice. Although patients with less-frequent angina and those with heart failure more often had their angina under-recognized, most variation was unrelated to patient and physician characteristics. The large variation across physicians suggests that some physicians are more accurate in assessing angina frequency than others. Standardized prospective use of a validated clinical tool, such as the Seattle Angina Questionnaire, should be tested as a means to improve recognition of angina and, potentially, improve appropriate treatment of angina.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  angina pectoris; coronary artery disease; quality of healthcare

Mesh:

Year:  2016        PMID: 27531922      PMCID: PMC5031528          DOI: 10.1161/CIRCOUTCOMES.116.002781

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  18 in total

1.  Medicare Program; Comprehensive Care for Joint Replacement Payment Model for Acute Care Hospitals Furnishing Lower Extremity Joint Replacement Services. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2015-11-24

2.  ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement.

Authors:  Joseph Drozda; Joseph V Messer; John Spertus; Bruce Abramowitz; Karen Alexander; Craig T Beam; Robert O Bonow; Jill S Burkiewicz; Michael Crouch; David C Goff; Richard Hellman; Thomas James; Marjorie L King; Edison A Machado; Eduardo Ortiz; Michael O'Toole; Stephen D Persell; Jesse M Pines; Frank J Rybicki; Lawrence B Sadwin; Joanna D Sikkema; Peter K Smith; Patrick J Torcson; John B Wong
Journal:  Circulation       Date:  2011-06-13       Impact factor: 29.690

Review 3.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

4.  Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population.

Authors:  N Brown; M Melville; D Gray; T Young; J Munro; A M Skene; J R Hampton
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

5.  Development and validation of a short version of the Seattle angina questionnaire.

Authors:  Paul S Chan; Philip G Jones; Suzanne A Arnold; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-09-02

6.  ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography.

Authors:  Manesh R Patel; Gregory J Dehmer; John W Hirshfeld; Peter K Smith; John A Spertus
Journal:  J Am Coll Cardiol       Date:  2012-01-30       Impact factor: 24.094

7.  Monitoring the quality of life in patients with coronary artery disease.

Authors:  J A Spertus; J A Winder; T A Dewhurst; R A Deyo; S D Fihn
Journal:  Am J Cardiol       Date:  1994-12-15       Impact factor: 2.778

8.  Health status predicts long-term outcome in outpatients with coronary disease.

Authors:  John A Spertus; Philip Jones; Mary McDonell; Vincent Fan; Stephan D Fihn
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

9.  Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.

Authors:  J A Spertus; J A Winder; T A Dewhurst; R A Deyo; J Prodzinski; M McDonell; S D Fihn
Journal:  J Am Coll Cardiol       Date:  1995-02       Impact factor: 24.094

10.  Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial.

Authors:  Suzanne V Arnold; David A Morrow; Yang Lei; David J Cohen; Elizabeth M Mahoney; Eugene Braunwald; Paul S Chan
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-06-02
View more
  15 in total

1.  Patient-Reported Outcomes in Cardiology.

Authors:  Daniel M Blumenthal; Jordan B Strom; Linda R Valsdottir; Sydney E Howard; Neil W Wagle; Kalon K L Ho; Daniel M Horn; Sandra M O'Keefe; Jason H Wasfy; Joshua P Metlay; Robert W Yeh
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-11

Review 2.  Update on the Management of Chronic Total Occlusions in Coronary Artery Disease.

Authors:  Kathleen Kearney; Ravi S Hira; Robert F Riley; Arun Kalyanasundaram; William L Lombardi
Journal:  Curr Atheroscler Rep       Date:  2017-04       Impact factor: 5.113

3.  Association between procedure appropriateness and patient-reported outcomes after percutaneous coronary intervention.

Authors:  Jesse Xiaolong Yang; Margaret J Stevenson; Linda Valsdottir; Kalon Ho; John A Spertus; Robert W Yeh; Jordan B Strom
Journal:  Heart       Date:  2019-12-19       Impact factor: 5.994

4.  Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights From the OPEN-CTO Registry.

Authors:  Yevgeniy Khariton; Sophia Airhart; Adam C Salisbury; John A Spertus; Kensey L Gosch; J Aaron Grantham; Dimitrios Karmpaliotis; Jeffrey W Moses; William J Nicholson; David J Cohen; William Lombardi; James Sapontis; James M McCabe
Journal:  JACC Cardiovasc Interv       Date:  2018-11-26       Impact factor: 11.195

5.  ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease : A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons.

Authors:  Manesh R Patel; John H Calhoon; Gregory J Dehmer; James Aaron Grantham; Thomas M Maddox; David J Maron; Peter K Smith
Journal:  J Nucl Cardiol       Date:  2017-10       Impact factor: 5.952

6.  Effect of angina under-recognition on treatment in outpatients with stable ischaemic heart disease.

Authors:  Mohammed Qintar; John A Spertus; Kensey L Gosch; John Beltrame; Faraz Kureshi; Ali Shafiq; Tracie Breeding; Karen P Alexander; Suzanne V Arnold
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2016-03-25

Review 7.  Using Patient-Reported Outcomes toAssess Healthcare Quality: Toward Better Measurement of Patient-Centered Care in Cardiovascular Disease.

Authors:  Raul Angel Garcia; John A Spertus
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-04-05

8.  Understanding How Patients Fare: Insights Into the Health Status Patterns of Patients With Coronary Disease and the Future of Evidence-Based Shared Medical Decision-Making.

Authors:  John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-03

9.  Validation of the Seattle angina questionnaire in women with ischemic heart disease.

Authors:  Krishna K Patel; Suzanne V Arnold; Paul S Chan; Yuanyuan Tang; Philip G Jones; Jianping Guo; Donna M Buchanan; Mohammed Qintar; Carole Decker; David A Morrow; John A Spertus
Journal:  Am Heart J       Date:  2018-04-21       Impact factor: 4.749

Review 10.  Interpretation of the Seattle Angina Questionnaire as an Outcome Measure in Clinical Trials and Clinical Care: A Review.

Authors:  Merrill Thomas; Philip G Jones; Suzanne V Arnold; John A Spertus
Journal:  JAMA Cardiol       Date:  2021-05-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.